A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Weight loss drugs like Ozempic and Wegovy dominated 2024. Securing insurance to cover the costs is a different challenge ...

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

Novartis, Eli Lilly and more put on their deal-making caps, Bristol Myers Squibb targets $2 billion in savings through 2027, sales continue to soar for Lilly and Novo Nordisk’s GLP-1s and Regeneron ...

It then launches into promotion of the company's compounded weight-loss medications. The backlash to the ad speaks to the ...

Scientists have created the most detailed map to date of the human hypothalamus, a crucial brain region that regulates body weight, appetite, sleep ...

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

Fitness and nutrition gurus like to make weight loss sound easy. But in reality, it’s often incredibly tough to incorporate ...

Healthcare sector shows strong performance in January amid signs of a brighter 2025, according to analysts. Read more here.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

It's calculated by dividing a person's weight in kilograms by their height in meters, squared. (kg/m2). While not perfect, this simple calculation is used as a standard way to measure where people ...